Viral Vector Manufacturing

CBM offers a full range of viral vector manufacturing services from process and analytical development to clinical and commercial supply to support every stage of your therapeutic development. Working with CBM represents a true partnership; where we offer expert knowledge to help you identify and develop your production methods and process, while ensuring quality is never compromised. CBM’s ‘Partner in Plant’ focused facility enables real-time collaboration and communication with our technical experts, while state-of-the-art equipment and automation allows us to offer unparalleled process monitoring and characterization.

At CBM, you can come to us with a blank slate or a developed process for transfer and we will take care of the rest. We can partner with you to select the ideal production platform, manufacture or source the appropriate grade plasmids and other critical materials, and optimize your processes and analytical assays. All with the end result of cGMP ready processes and analytics to arrive at the patient-ready drug product at unparalleled speed without compromising quality.

Our facilities and manufacturing operations are designed to support production from starting materials such as cell and viral banks all the way through drug substance and drug product across multiple production platforms. Our services enable the production of a variety of viral vectors, including AAV, adenovirus, and lentivirus, and our equipment configurations are flexible to fit your needs. Our facilities are fully segregated, with multiple engineering controls in place to prevent cross-contamination to ensure maximum flexibility while never compromising safety and quality.

Our manufacturing facilities and supporting systems are created with the end goal in mind – taking your product through to commercialization. CBM’s facilities and systems are designed to meet both clinical and commercial regulatory requirements, ensuring that once your process scales up, you never have to go anywhere else.